NEW YORK (GenomeWeb) – Sequenom said this week that its wholly owned subsidiary Sequenom Laboratories signed a national agreement with an unnamed insurance company for coverage of the MaterniT21 Plus non-invasive prenatal test. It is the third national coverage deal signed by Sequenom for the test. The insurer covers 13 million lives in the US and brings the total number of covered lives under agreement by the laboratory's diagnostic services to more than 140 million lives, Sequenom said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.